Altered nonspecific lymphocyte cytotoxicity in bronchoalveolar lavage of lung transplant recipients: Can it be useful in monitoring rejection or infection?

Transplantation

Volumn 62, Issue 9, 1996, Pages 1262-1267

  Shennib, Hani ^a,b   Lee, Allan G L ^a   Serrick, Cyril ^a   Giaid, Adel ^a  

^a Montreal Lung Transplant Program   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRONCHIOLITIS; BRONCHOSCOPY; CELL MEDIATED CYTOTOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; HUMAN; HUMAN CELL; INFECTION; LUNG FUNCTION; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPHOCYTE; MACROPHAGE; NATURAL KILLER CELL; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSBRONCHIAL BIOPSY;

BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CYTOTOXICITY, IMMUNOLOGIC; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030449555     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199611150-00015     Document Type: Article

References (28)

1. Scott JP, Higgenbottam TW, Sharples L, et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 1991; 51: 813.
2. Milne DS, Gascoigne AD, Ashcroft T, et al. Organizing pneumonia following pulmonary transplantation and the development of obliterative bronchiolitis. Transplantation 1994; 57: 1757.
3. Keenan RJ, Lega ME, Dummer JS, et al. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51: 433.
4. Scott JP. The role of bronchoscopy in lung transplantation. In: Shennib H, ed. Medical intelligence unit: immunology of the lung allograft. Austin, TX: R.G. Landes Company, 1995: 45.
5. Nguyen DM, Mulder DS, Shennib H. Lectin dependent cell-mediated cytotoxicity and natural killer function in rejecting and infected lung allografts. Transplantation 1993; 55: 1250.
6. Epstein FH. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365.
7. Prop J, Wagenaar-Hilbers JPA, Petersen AH, et al. Characteristics of cells lavaged from rejecting lung allografts in rats. Transplant Proc 1988; 20: 217.
8. Venaille TJ, Mendis AH, Philips MJ, et al. Role of neutrophils in mediating human epithelial cell detachment from native basement membrane. J Allergy Clin Immunol 1995; 95: 597.
9. Devouassoux G, Pison C, Blanc-Jouvan F, et al. Bronchoalveolar lavage during acute rejection and bronchiolitis obliterans syndrome in lung transplant patients. Eur Respir J 1994; 7: S294.
10. Zeevi A, Dauber J, Yousem SA, et al. Immunologic alterations in chronic lung rejection. In: Shennib H, ed. Medical intelligence unit: immunology of the lung allograft. Austin, TX: R.G. Landes Company, 1995: 73.
11. Robinson BWS, Pinkston P, Crystal RG. Natural killer cells are present in the normal human lung but are functionally impotent. J Clin Invest 1984; 74: 942.
12. Trinchieri G. Murphy M, Perussia B. Regulation of hematopoiesis by T lymphocytes and natural killer cells. Crit Rev Oncol Hematol 1987; 7: 219.
13. Djeu JY. Natural killer cells: role in resistance to cancer and infection. J Fla Med Assoc 1991; 78: 763.
14. Hoffman RA, Jordan ML, Ascher NL, Simmons RL. The contribution of natural killer cells to the allograft response. Transplant Proc 1988; 20: 186.
15. Philips JH, Lanier LL. Lectin-dependent and anti-CDS-induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen. J Immunol 1986; 136: 1579.
16. Hruban RH, Beschorner WE, Baumgartner WA, et al. Diagnosis of lung allograft rejection by bronchial intraepithelial Leu-7 positive T lymphocytes. J Thorac Cardiovasc Surg 1988; 96: 939.
17. Norin A, Kamholtz S, Pinsker K, et al. Concanavalin A dependent cell-mediated cytotoxicity in bronchoalveolar lavage fluid: correlation with lung allograft rejection in mongrel dogs during cyclosporine dose tapering. Transplantation 1986; 42: 466.
18. Higgenbottam TW, Stewart S, Penketh A, et al. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant recipients. Transplantation 1988; 46: 532.
19. Holland VA, Cagle PT, Windsor GP, et al. Lymphocyte subset population in bronchiolitis obliterans after heart-lung transplantation. Transplantation 1990; 5: 955.
20. Uyama T, Winter JB, Groen G, et al. Late airway changes caused by chronic rejection in rat lung allografts. Transplantation 1992; 54: 809.
21. Chang SC, Hsu HK, Perng RP, et al. Increased expression of MHC class II antigens in rejecting canine lung allografts. Transplantation 1990; 49: 1158.
22. Taylor P, Rose M, Yacoub M. Expression of MHC antigens in normal lungs and transplanted lungs with obliterative bronchiolitis. Transplantation 1989; 48: 506.
23. Higgenbottam T, Stewart S, Penketh A, et al. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation 1988; 46: 532.
24. Yousem SA, Paradis IL, Dauber JH, et al. Efficacy of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans in heart-lung transplant recipients. Transplantation 1989; 47: 893.
25. Yousem SA, Paradis I, Griffith BP. Can transbronchial biopsy aid in the diagnosis of bronchiolitis obliterans in lung transplant recipients? Transplantation 1993; 57: 151.
26. Kramer MR, Stoehr C, Whang JL, et al. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy. J Heart Lung Transplant 1993; 12: 675.
27. Adoumie R, Serrick C, Giaid A, Shennib H. Early cellular events in the lung allograft. Ann Thorac Surg 1992; 54: 1071.
28. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12: 713.